Speaker illustration

Doctor Marina Panova-Noeva

Boehringer Ingelheim, Ingelheim am Rhein (Germany)

Clinical determinants of MYDGF in a heart failure population - results from the Emperor biomarker program

Event: ESC Congress 2025

Topic: Pathophysiology and Mechanisms

Session: Novel biomarkers for risk assessment of your patient with heart failure

Thumbnail